Uncovering the Genetic Architecture of Optic Nerve Integrity Estimates through Genome-wide Association Study Meta-analyses

Read full text
Authors: Asma M. Aman, Santiago Diaz-Torres, Samantha Sze-Yee Lee, Sjoerd J. Driessen, Victor A. de Vries, Frank C.T. van der Heide, Antonia Kolovos, Joshua M. Schmidt, Henry N. Marshall, Lania Saleh, Alicia Schulze, Gabriëlla A.M. Blokland
+28 more Carroll A.B. Webers, Carla J. H Van Der Kallen, Anke Wesselius, Ilja C.W. Arts, Freekje van Asten, Mathias Gorski, Martina E. Zimmermann, Klaus J. Stark, Iris M. Heid, Terri L. Young, Louis R Pasquale, Ayellet Segre, Janey L Wiggs, Anthony P Khawaja, Alex William Hewitt, Alexander K. Schuster, Tos T.J.M. Berendschot, Alberta A. H. J. Thiadens, Karin A. van Garderen, C. Klaver, Pirro G. Hysi, Christopher J. Hammond, Caroline Brandl, Jamie E. Craig, Wishal D. Ramdas, Stuart MacGregor, David A Mackey, Puya Gharahkhani
Cited by: 1
References: 64

Abstract

Abstract We conducted the first genome-wide association meta-analyses of global and sectoral peripapillary retinal nerve fibre layer (pRNFL) thickness and Bruch’s membrane opening-minimum rim width (BMO-MRW), the major optic nerve head structural and neurodegeneration biomarkers, including up to 25,942 and 12,080 participants, respectively, from the International Glaucoma Genetics Consortium. We identified 9 global pRNFL thickness and 9 global BMO-MRW loci, along with 28 and 19 loci for pRNFL and BMO-MRW sectors, respectively, comprising both shared and sector-specific loci. To identify intraocular pressure (IOP)-independent drug targets, global pRNFL thickness and BMO-MRW were conditioned on IOP. IOP-independent loci were then prioritised to identify candidate causal genes using transcriptome-wide association study and colocalization analysis. Several genes, such as NMNAT2 and TRIOBP, had robust associations with both phenotypes, with potential IOP-independent therapeutic translation for glaucoma. Overall, we identified novel loci for pRNFL thickness and BMO-MRW, highlighting potential drug-target genes acting independently from IOP, and elucidating genetic differences among pRNFL sectors.

Fields of Study & Subjects

Glaucoma and retinal disorders Retinal Development and Disorders Retinal Diseases and Treatments

Publication details

Journal / source
medRxiv
Publisher
openRxiv
Publication date
6 February 2026
Language
EN
Document type
Preprint